Ionis Pharmaceuticals Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| PFE | Pfizer | Outperform |
2
|
$25.39 | $32.87 | 20.13% | 6 | $143.77B |
| AMGN | Amgen | Outperform |
4
|
$262.75 | $303.65 | 20.74% | 8 | $140.93B |
| SAN | Sanofi | Outperform |
16
|
85.23€ | 102.80€ | 26.72% | 9 | 106.41€B |
| REGN | Regeneron Pharmaceuticals | Outperform |
2
|
$893.99 | $961.26 | 17.45% | 8 | $96.07B |
| CSL | CSL | Outperform |
12
|
$271.40 | $205.51 | -25.14% | 5 | $131.15B |
| 4568 | Daiichi Sankyo Company | Buy |
4
|
¥4.54k | ¥5.24k | 27.87% | 0 | ¥8.70T |
| 4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.09k | ¥4.74k | 13.72% | 0 | ¥6.42T |
| MRNA | Moderna | Outperform |
16
|
$102.00 | $135.42 | 21.96% | 1 | $39.05B |
| BIIB | Biogen | Outperform |
10
|
$190.52 | $299.62 | 53.26% | 13 | $27.69B |
| ALNY | Alnylam Pharmaceuticals Inc | Outperform |
7
|
$145.16 | $245.24 | 48.11% | 7 | $18.36B |
| BMRN | BioMarin Pharmaceutical | Outperform |
10
|
$90.07 | $111.56 | 20.68% | 5 | $17.09B |
| INCY | Incyte | Outperform |
9
|
$52.82 | $77.05 | 46.16% | 8 | $11.86B |
| SRPT | Sarepta Therapeutics | Outperform |
6
|
$116.55 | $158.66 | 42.00% | 6 | $10.94B |
| JAZZ | Jazz Pharmaceuticals | Outperform |
14
|
$109.27 | $188.32 | 73.88% | 4 | $8.36B |
| EXEL | Exelixis | Outperform |
16
|
$22.49 | $26.44 | 20.05% | 5 | $6.21B |
| NTLA | Intellia Therapeutics | Outperform |
8
|
$21.32 | $75.84 | 228.33% | 21 | $2.51B |
| 4516 | Nippon Shinyaku | Outperform |
18
|
¥4.24k | ¥8.34k | 53.16% | 0 | ¥329.22B |
| DYN | Dyne Therapeutics | Buy |
5
|
$23.65 | $28.13 | 52.22% | 0 | $2.06B |
| DCPH | Deciphera Pharmaceuticals | Outperform |
6
|
$14.23 | $23.40 | 72.17% | 4 | $1.29B |
| BCRX | BioCryst Pharmaceuticals | Outperform |
7
|
$4.50 | $14.09 | 133.33% | 2 | $1.19B |
| WVE | Wave Life Sciences | Outperform |
6
|
$4.80 | $9.21 | 181.25% | 3 | $768.25M |
| PHARM | Pharming Group N.V. | Buy |
16
|
0.87€ | 1.85€ | 135.63% | 2 | 701.94€M |
| FULC | Fulcrum Therapeutics | Outperform |
9
|
$7.06 | $10.21 | 105.38% | 7 | $680.67M |
| KALV | KalVista Pharmaceuticals | Buy |
7
|
$11.50 | $20.80 | 204.35% | 0 | $597.02M |
| ABUS | Arbutus Biopharma | Outperform |
9
|
$2.73 | $6.34 | 98.90% | 0 | $474.02M |
| STOK | Stoke Therapeutics | Buy |
4
|
$11.65 | $19.33 | 80.26% | 3 | $318.38M |
| PYC | PYC Therapeutics | Buy |
8
|
$0.10 | $0.30 | 250.00% | 1 | $294.90M |